Scientists and public health advocates see disconnects between what the Trump administration says about health — notably, in ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

CDC advisers recommend Merck's Enflonsia to protect babies from RSV, addressing the leading cause of infant hospitalization ...

Meissner was previously listed in April as a consultant to the RSV vaccines work group for the CDC committee, before Kennedy ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

Landmark Studies Leading to Scientific Breakthrough SCHARP played an instrumental role in several landmark studies over the years. In 2011 a study published in the New England Journal of Medicine ...

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...